Central Alerting System: Dexamethasone in the treatment of COVID-19: Implementation and management of supply for treatment in hospitals

17 June 2020

Dexamethasone has been demonstrated to have a clear place in the management of hospitalised patients with COVID-19. Dexamethasone was not used in pregnant women.

Clinicians should therefore consider dexamethasone for the management of hospitalised patients with COVID-19 who require oxygen or ventilation.

Out of hospital treatment is not appropriate.

There is no current or anticipated constraint on supply of the medicine in the UK.

More information can be found here.

ENDS